Citation Impact
Citing Papers
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
TLR4 Mediates Vaccine-Induced Protective Cellular Immunity to Bordetella pertussis : Role of IL-17-Producing T Cells
2006
Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.
2017 Standout
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Hospital admissions for pertussis in Spain, 1995–1998
2001
The current status of EHDI programs in the United States
2003
Interventions for the eradication of methicillin-resistantStaphylococcus aureus(MRSA) in people with cystic fibrosis
2013
Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis
2003
Quality of web based information on treatment of depression: cross sectional survey
2000
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
The case for maternal vaccination against pertussis
2007
Pertussis Is a Frequent Cause of Prolonged Cough Illness in Adults and Adolescents
2001
Poverty and obesity: the role of energy density and energy costs
2004 Standout
How to Make Sense of Pertussis Immunogenicity Data
2001
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
1998
Antibody Responses to Bordetella pertussis Antigens and Clinical Correlations in Elderly Community Residents
2000
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
A model for immunological correlates of protection
2005
Immunologic correlates of protection induced by vaccination
2001
Newborn Hearing Screening — A Silent Revolution
2006 Standout
Relationship between structure and neutralizing activity of rabbit tetanus antibodies elicited by acellular and whole-cell pertussis DTP vaccines
1998
Vaccines: Correlates of Vaccine‐Induced Immunity
2008
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Acellular Pertussis Vaccines--A Solution to the Pertussis Problem
1993
Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT Study
2004
The Increasing Incidence of Pertussis in Massachusetts Adolescents and Adults, 1989–1998
2000
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
2012 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Pertussis in the Preantibiotic and Prevaccine Era, with Emphasis on Adult Pertussis
1999
Protection againstBordetella pertussisin Mice in the Absence of Detectable Circulating Antibody: Implications for Long‐Term Immunity in Children
2000
Parapertussis and pertussis: Differences and similarities in incidence, clinical course, and antibody responses
1999
Early hearing detection and intervention programs: Opportunities for genetic services
2004
Cost-Effectiveness of Blood Cultures for Adult Patients with Cellulitis
1999
Trends in Pertussis Among Infants in the United States, 1980-1999
2003
Historical Review Of Pertussis And The Classical Vaccine
1996
Determination of Serum Antibody toBordetella pertussisAdenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis
2004
A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells
2006 Standout
Evaluation of Strategies for Use of Acellular Pertussis Vaccine in Adolescents and Adults: A Cost-Benefit Analysis
2004
Frequency of Unrecognized Bordetella pertussis Infections in Adults
1995
Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination
1998
Antibody blocks acquisition of bacterial colonization through agglutination
2014
Pertussis Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy
2007
Epidemiological, Clinical, and Laboratory Aspects of Pertussis in Adults
1999
Deaths from pertussis are underestimated in England
2002
Neonatal pertussis
2000
Household Contact Study of Bordetella pertussis Infections
1995
Population‐Based Incidence of Pertussis among Adolescents and Adults, Minnesota, 1995–1996
2001
Nutrition and Health Outcomes Associated with Food Insecurity and Hunger
1999
Locating proteins in the cell using TargetP, SignalP and related tools
2007 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Neonatal and early life vaccinology
2001
A Clinical Validation of Bordetella pertussis and Bordetella parapertussis Polymerase Chain Reaction: Comparison with Culture and Serology using Samples from Patients with Suspected Whooping Cough from a Highly Immunized Population
1996
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells
2007 Standout
The Bordetellae: lessons from genomics
2004
Sensorineural hearing loss in children
2005 Standout
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
2009 Standout
Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A)
2010 Standout
Correlation between Pertussis Toxin IgG Antibodies in Postvaccination Sera and Subsequent Protection against Pertussis
2000
Increase in deaths from pertussis among young infants in the United States in the 1990s
2003
Use of the Internet and E-mail for Health Care Information
2003 Standout
Biomaterials for vaccine-based cancer immunotherapy
2018
Bordetella pertussis and Chronic Cough in Adults
1999
The biofilm matrix
2010 Standout
Phagocytosis ofBordetella pertussisIncubated with Convalescent Serum
2003
Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines
2003
Cell‐Mediated Immunity and Antibody Responses toBordetella pertussisAntigens in Children with a History of Pertussis Infection and in Recipients of an Acellular Pertussis Vaccine
2000
Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter
1999
PROP taster status interacts with the built environment to influence children's food acceptance and body weight status
2012
Evaluation of Pertussis in U.S. Marine Corps Trainees
1997
What Is Wrong with Pertussis Vaccine Immunity?
2017
Whooping Cough Caused by <EMPH TYPE="ITAL">Bordetella pertussis</EMPH> and <EMPH TYPE="ITAL">Bordetella parapertussis</EMPH> in an Immunized Population
1998
Staphylococcus and biofilms
2002
Bacterial silver resistance: molecular biology and uses and misuses of silver compounds
2003
Polymerase chain reaction (PCR) compared with conventional identification in culture for detection of Bordetella pertussis in 7153 children
1997
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Mechanisms of bordetella pathogenesis
2001
Update on respiratory infection caused by Bordetella parapertussis
1999
The Science and Fiction of Pertussis Vaccines
1999
Family Food Insufficiency, but Not Low Family Income, Is Positively Associated with Dysthymia and Suicide Symptoms in Adolescents
2002
Mice lacking Dfna5 show a diverging number of cochlear fourth row outer hair cells
2005
Description of a multiplex Bordetella pertussis and Bordetella parapertussis LightCycler® PCR assay with inhibition control
2003
Recent developments in pertussis
2006
An Epidemic of Pertussis Among Elderly People in a Religious Institution in The Netherlands
1999
The need for universal neonatal hearing screening–some aspects of epidemiology and identification
1999
Stress-induced immune dysfunction: implications for health
2005 Standout
Frequency of Serological Evidence of Bordetella Infections and Mixed Infections with other Respiratory Pathogens in University Students with Cough Illnesses
2000
Airway Mucus Function and Dysfunction
2010 Standout
Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine
2003
Bordetella pertussis Infection: Pathogenesis, Diagnosis, Management, and the Role of Protective Immunity
2000
Measuring Food Insecurity and Hunger in the United States: Development of a National Benchmark Measure and Prevalence Estimates
1999
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
2016 Standout
THE NEUROENDOCRINOLOGY OF CHILDHOOD OBESITY
2001
Pertussis: the trials and tribulations of old and new pertussis vaccines
1992
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore
2005
La coqueluche maligne du petit nourrisson
2003
Empirical Studies Assessing the Quality of Health Information for Consumers on the World Wide Web
2002 Standout
Crucial Role of Antibodies to Pertactin inBordetella pertussisImmunity
2003
Neonatal Hyperbilirubinemia
2001 Standout
Keeping Pace with the Elusive Bordetella pertussis
2002
Defining trained immunity and its role in health and disease
2020 Standout
Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials
1997
Live attenuated vaccines against pertussis
2014
MLL-mediated transcriptional gene regulation investigated by gene expression profiling
2003
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
Prolonged Afebrile Nonproductive Cough Illnesses in American Soldiers in Korea: A Serological Search for Causation
2000
Morbidity of Pertussis in Adolescents and Adults
2000
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Adolescent and adult pertussis vaccination: computer simulations of five new strategies
2004
Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults
2005
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Biological performances of poly(ether)urethane–silver nanocomposites
2007
Environmental Transformations of Silver Nanoparticles: Impact on Stability and Toxicity
2012 Standout
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Role of Systemic and Mucosal Immune Responses in Reciprocal Protection against Bordetella pertussis and Bordetella parapertussis in a Murine Model of Respiratory Infection
2003
Identification and Cloning of waaF ( rfaF ) from Bordetella pertussis and Use To Generate Mutants of Bordetella spp. with Deep Rough Lipopolysaccharide
1998
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
2017
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Laboratory diagnosis of pertussis: state of the art in 1997
1997
The Christchurch Health and Development Study: Review of Findings on Child and Adolescent Mental Health
2001
Cell-Mediated Immune Responses in Four-Year-Old Children after Primary Immunization with Acellular Pertussis Vaccines
1999
Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory
1997
Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and Persistent Cough in Children
1999
IL-17 and Th17 Cells
2009 Standout
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin
1999
Sustained Efficacy During the First 6 Years of Life of 3-Component Acellular Pertussis Vaccines Administered in Infancy: The Italian Experience
2001
Role ofBordetellaO Antigen in Respiratory Tract Infection
2002
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
2015
Bordetella pertussisVirulence Factors Affect Phagocytosis by Human Neutrophils
2000
Neutralizing Antibodies to Adenylate Cyclase Toxin Promote Phagocytosis ofBordetella pertussisby Human Neutrophils
2000
Reactogenicity and Immunogenicity at Preschool Age of a Booster Dose of Two Three-Component Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children Primed in Infancy With Acellular Vaccines
2001
Evaluation of Real-Time PCR for Detection of and Discrimination between Bordetella pertussis , Bordetella parapertussis , and Bordetella holmesii for Clinical Diagnosis
2003
Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production
2000
Polymer nanotechnology: Nanocomposites
2008 Standout
A Controlled Study of the Relationship BetweenBordetella pertussisInfections and Sudden Unexpected Deaths Among German Infants
2004
Lipopolysaccharide Endotoxins
2002 Standout
Role of Antibodies in Immunity to Bordetella Infections
2003
Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis
1996
Genetic Basis for Lipopolysaccharide O-Antigen Biosynthesis in Bordetellae
1999
Prosthetic Joint Infection
2014 Standout
Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions
2004
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
Comparison of bipA Alleles within and across Bordetella Species
2003
Bordetella parapertussis Infection in Children: Epidemiology, Clinical Symptoms, and Molecular Characteristics of Isolates
1998
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Nosocomial Pertussis in the Nineties
1995
Distinct T‐cell subtypes induced with whole cell and acellular pertussis vaccines in children
1998
Type V Protein Secretion Pathway: the Autotransporter Story
2004
Validation of nested Bordetella PCR in pertussis vaccine trial
1996
Real-Time PCR Assay Targeting IS 481 of Bordetella pertussis and Molecular Basis for Detecting Bordetella holmesii
2001
Correlates of Protection Induced by Vaccination
2010 Standout
Prevalence and Incidence of Adult Pertussis in an Urban Population
1996
Works of K Stehr being referenced
Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany
1994
Evidence of Efficacy of the Lederle/Takeda Acellular Pertussis Component Diphtheria and Tetanus Toxoids and Pertussis Vaccine but Not the Lederle Whole‐Cell Component Diphtheria and Tetanus Toxoids and Pertussis Vaccine AgainstBordetella parapertussisInfection
1999
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
1998
Bordetella pertussis infections and sudden unexpected deaths in children
1996
Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months of age☆☆Results of this study were presented at the annual meetings of the German Society for Paediatrics and Adolescent Medicine, September 1997, Vienna (Austria) and the German Society for Paediatric Infectious Diseases, November 1997, Berlin (Germany).
2000
Antimicrobial activity and biocompatibility of polyurethane and silicone catheters containing low concentrations of Silver: A new perspective in prevention of polymer-associated foreign-body-infections
1995
The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin‐7
1994
Aminoglykoside bei Patienten mit Mukoviszidose und pulmonaler Exazerbation: Vergleich von Einmal- und Dreimalgabe
1993
Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany
1993
Pertussis in German Adults
1995
Surrogate Serologic Tests for the Prediction of Pertussis Vaccine Efficacya
1995
Serious pertussis overlooked in infants
1992
Serologic Response and Antibody‐Titer Decay in Adults with Pertussis
2004
Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany
1995
Comparison of Values of Antibody to Bordetella pertussis Antigens in Young German and American Men
1995
Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis
1994
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
1997
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine
2002
Pertussis in German adults
1994
Bordetella pertussis infections and sudden unexpected deaths in children
1996
Clinical Findings in Bordetella pertussis Infections: Results of a Prospective Multicenter Surveillance Study
1997
Clinical Validation of a Polymerase Chain Reaction Assay for the Diagnosis of Pertussis by Comparison With Serology, Culture, and Symptoms During a Large Pertussis Vaccine Efficacy Trial
2000
The Effect of Investigator Compliance (Observer Bias) on Calculated Efficacy in a Pertussis Vaccine Trial
1998
A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine
1998
Comparative Efficacy of the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine and Lederle Whole-Cell Component DTP Vaccine in German Children After Household Exposure
1998